GSH: Glutathione-rich Foods for Type 2 Diabetes

Sponsor
University of California, San Diego (Other)
Overall Status
Completed
CT.gov ID
NCT04386187
Collaborator
(none)
12
1
2
8.1
1.5

Study Details

Study Description

Brief Summary

The purpose of this research study is to find out whether certain plant-based foods may be beneficial for individuals with type 2 diabetes. To meet the goal, study participants will be fed known amounts of foods and nutrients. Before and after participants have eaten the food, they will self-measure height, weight, and waist circumference and study staff will administer questionnaires. Blood samples will be taken at a local lab to measure blood sugar and blood lipids.All study appointments will be conducted online.

Condition or Disease Intervention/Treatment Phase
  • Other: GSH Foods
  • Other: Nutrition education about glutathione sources in the diet
  • Other: Standard of care nutrition education for type 2 diabetes
N/A

Detailed Description

This research study is a randomized, controlled trial that will evaluate whether diet and nutrition education on, and short-term partial feeding of, specific plant foods high in the antioxidant glutathione will impact total glutathione status, gamma-glutamyltransferase (GGT) activity, glucose control or insulin sensitivity in people with type 2 diabetes. Dietary education will include information on plant sources of glutathione, as well as, cooking methods to reduce glycation and lipid peroxidation during cooking, which may indirectly alter glutathione status by reduce demand for elimination of these compounds. Participants will be randomized to one of two groups: the educational intervention plus partial feeding of two small meals per day vs. a wait list control group that will receive standard advice on nutrition for diabetes. After 12 weeks, the intervention group will no longer receive foods, but will be followed for 12 additional weeks to determine if lasting effects are achieved. After 12 weeks, the control group will receive access to the educational materials, but will not receive study foods, to see if the educational intervention alone impacts food/nutrition choices. Both groups will have lab measures (as described above) again after this additional 12 weeks, for a total duration of 24 weeks in the trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
This is a partial controlled-feeding trial in which participants will be initially randomized to a "food intervention" or "education control" and then will be crossed-over after 12 weeks.This is a partial controlled-feeding trial in which participants will be initially randomized to a "food intervention" or "education control" and then will be crossed-over after 12 weeks.
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Effects of the "Glutathione Support for Health (GSH)" Plan on Glutathione Status in Type 2 Diabetes
Actual Study Start Date :
Jul 28, 2020
Actual Primary Completion Date :
Apr 2, 2021
Actual Study Completion Date :
Apr 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1: Experimental Feeding

Small glutathione-rich meals will be prepared and delivered to participants for 12 weeks.

Other: GSH Foods
The intervention consists of customized foods/small meals that have been designed to be high in a single nutrient called glutathione (GSH).

Other: Nutrition education about glutathione sources in the diet
Four videos will outline food sources of glutathione, cooking methods to reduce systemic requirements for glutathione, food sources of nutrient cofactors for glutathione production and other related content.

Active Comparator: Arm 2: Education Control

Standard of care medical nutrition education for type 2 diabetes will be provided in the form of electronic handouts and web-based resources.

Other: Standard of care nutrition education for type 2 diabetes
The educational control is provided with information on standard dietary interventions for diabetes as electronic handouts and web links.

Outcome Measures

Primary Outcome Measures

  1. Total glutathione [12 weeks]

    Total glutathione concentration in the blood

  2. gamma-glutamyltransferase (GGT) [12 weeks]

    Measure of glutathione demand in the blood

Secondary Outcome Measures

  1. Fasting glucose [12 weeks]

    Serum glucose concentration while fasting

  2. Fasting insulin [12 weeks]

    Plasma insulin concentration while fasting

  3. Hemoglobin A1c [12 weeks]

    Measure of glycemic control

  4. Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) [12 weeks]

    Estimate of insulin resistance

  5. Low density lipoprotein concentration (LDL-c) [12 weeks]

    concentration of LDL lipoproteins in serum

  6. High density lipoprotein concentration (HDL) [12 weeks]

    concentration of HDL lipoproteins in serum

  7. Triglycerides [12 weeks]

    concentration of triglycerides in serum

Other Outcome Measures

  1. Total glutathione [24 weeks]

    Total glutathione concentration in the blood

  2. gamma-glutamyltransferase (GGT) [24 weeks]

    Measure of glutathione demand in the blood

  3. Fasting insulin [24 weeks]

    Plasma insulin concentration while fasting

  4. Fasting glucose [24 weeks]

    Serum glucose concentration while fasting

  5. Hemoglobin A1c [24 weeks]

    Measure of glycemic control

  6. Homeostasis Assessment Index of Insulin Resistance (HOMA-IR) [24 weeks]

    Estimate of insulin resistance

  7. Low density lipoprotein concentration (LDL-c) [24 weeks]

    concentration of LDL lipoproteins in serum

  8. High density lipoprotein concentration (HDL) [24 weeks]

    concentration of HDL lipoproteins in serum

  9. Triglycerides [24 weeks]

    concentration of triglycerides in serum

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men and women

  • Ages 18 to 65

  • Type 2 diabetes

  • Free of self-reported acute and confounding chronic diseases (e.g., heart failure, kidney disease, liver disease, gastrointestinal disorder) based on a standardized medical history questionnaire

  • Free of alcoholism, smoking and major cardiovascular event with the past 6 months

  • Not on insulin to help manage diabetes

  • Planning on staying in the San Diego area for the next 6 months

  • Willing to select plant-based foods from a "menu" and eat the selected foods provided by the study team

  • Have access to the internet and a computer

  • Willing to view 4 weekly educational classes online, followed by periodic telephone and email contacts

  • Agree to schedule and complete periodic questionnaires and measurements during up to four total online appointments

Exclusion Criteria:
  • Alcoholism, smoking and recent cardiovascular events

  • Individuals will be excluded if they report any dietary restrictions, allergies or preferences

  • Unsuitability based on screening visit

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, San Diego San Diego California United States 92093

Sponsors and Collaborators

  • University of California, San Diego

Investigators

  • Principal Investigator: Ryan Bradley, ND, MPH, University of California, San Diego

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ryan Bradley, Assistant Professor, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT04386187
Other Study ID Numbers:
  • 180215
First Posted:
May 13, 2020
Last Update Posted:
Jan 21, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ryan Bradley, Assistant Professor, University of California, San Diego
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 21, 2022